Literatur
- 1
Bartram C R, de Klein A, Hagemeijer A. et al .
Translocation of c-abl oncogene
correlates with the presence of a Philadelphia chromosome in chronic
myelocytic leukaemia.
Nature.
1983;
306
277-280
- 2
Faderl S, Talpaz M, Estrov Z, Kantarjian H M.
Chronic
Myelogenous Leukemia: Biology and Treatment.
Ann Intern
Med.
1999;
131
207-219
- 3
Faderl S, Talpaz M, Estrow Z, O`Brien S, Kurzrock R, Kantarjian H M.
The biology
of chronic myeloid leukemia.
N Engl J Med.
1999;
341
164-172
- 4
Hasford J, Pfirrmann J, Hehlmann R. et al .
A new prognostic score for survival of
patients with chronic myeloid leukemia treated with interferon alfa.
J
Nat Cancer Inst.
1998;
90
850-858
- 5
Hehlmann R, Heimpel H, Hasford J. and the German CML Study Group .
Randomized comparison
of interferon-alpha with busulfan and hydroxyurea in chronic myelogenous
leukaemia (CML).
Blood.
1994;
84
4064-4077
- 6
Kantarijan H M, Keating M J, Talpaz M. et al .
Chronic myelogenous leukemia
in blast crisis. Analysis of 242 patients.
Amer J Med.
1987;
83
445-454
- 7
Rowley J D.
A
new consistent chromosomal abnormality in chronic myelogenous leukaemia
identified by quinacrine fluorescence and Giemsa staining.
Nature.
1973;
243
290-293
- 8
Sawyers C L.
Chronic
myeloid leukemia.
N Engl J Med.
1999;
340
1330-1339
- 9
Witte O N. et al .
Role of the BCR/ABL oncogene in
human leukemia.
Cancer Res.
1993;
53
485-489
Dr. med. Oliver J. Stoetzer
Hämato-Onkologische Schwerpunktpraxis am Rotkreuzplatz
Winthirstraße 7
80639 München
Phone: 089/557272
Fax: 089/55027179
Email: ojstoetzer@aol.com
